Nektar Therapeutics (NKTR) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free NKTR Stock Alerts $1.32 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBiolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseasesglobenewswire.com - April 24 at 7:00 AMNektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Hold" by Analystsamericanbankingnews.com - April 24 at 2:48 AMNatural Killer (NK) Cell Therapy Pipeline Research Report 2024: Comprehensive Insights About 100+ Companies and 185+ Pipeline Drugsfinance.yahoo.com - April 20 at 8:58 AMNektar regains Nasdaq compliance with bid priceinvesting.com - April 20 at 12:52 AMNektar Therapeutics Sees Something In The Data And Puts Its Drug To The Testseekingalpha.com - April 10 at 1:44 AMNektar Therapeutics (NASDAQ:NKTR) Sees Large Growth in Short Interestmarketbeat.com - April 1 at 7:56 PM“A fascinating listen that sometimes sounds like a missing 10cc album plus a little Be Box Deluxe”: Nektar’s Recycled 5CD setyahoo.com - March 29 at 5:45 PMNektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conferenceprnewswire.com - March 22 at 2:00 PMGSA Capital Partners LLP Increases Position in Nektar Therapeutics (NASDAQ:NKTR)marketbeat.com - March 10 at 7:48 AMWilliam Blair Equities Analysts Reduce Earnings Estimates for Nektar Therapeutics (NASDAQ:NKTR)marketbeat.com - March 7 at 6:40 AMNektar Therapeutics to Post FY2026 Earnings of ($1.05) Per Share, William Blair Forecasts (NASDAQ:NKTR)marketbeat.com - March 6 at 8:32 AMNektar Therapeutics (NASDAQ:NKTR) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 5 at 2:06 PMNektar Therapeutics' (NKTR) Market Perform Rating Reaffirmed at William Blairmarketbeat.com - March 5 at 11:43 AMQ4 2023 Nektar Therapeutics Earnings Callfinance.yahoo.com - March 5 at 9:06 AMNektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areataprnewswire.com - March 5 at 9:00 AMNektar Therapeutics (NASDAQ:NKTR) Given Average Rating of "Hold" by Brokeragesmarketbeat.com - March 5 at 1:33 AMNektar Therapeutics Q4 Loss decreases, but misses estimatesmarkets.businessinsider.com - March 4 at 6:05 PMNektar Therapeutics (NKTR) Reports Fiscal Year-End and Q4 2023 Resultsfinance.yahoo.com - March 4 at 6:05 PMNektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Resultsprnewswire.com - March 4 at 4:15 PMNektar Therapeutics Announces $30 Mln Private Placement Financing With TCGX; Stock Up In Premarketmarkets.businessinsider.com - March 4 at 1:05 PMNektar Therapeutics Announces $30 Million Private Placement Financing with TCGXprnewswire.com - March 4 at 8:30 AMNektar Therapeutics earnings: here's what Wall Street expectsmarkets.businessinsider.com - March 3 at 10:01 AMNektar Therapeutics Earnings Previewbenzinga.com - March 1 at 11:43 AMNektar Management to Present at the TD Cowen 44th Annual Health Care Conferenceprnewswire.com - February 27 at 6:00 PMLynx1 Capital Management LP Takes $1.05 Million Position in Nektar Therapeutics (NASDAQ:NKTR)marketbeat.com - February 27 at 3:43 PMNektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Marketsprnewswire.com - February 26 at 6:00 PMAcadian Asset Management LLC Acquires 3,230,368 Shares of Nektar Therapeutics (NASDAQ:NKTR)marketbeat.com - February 24 at 6:45 AMNektar to play final UK live show at Nene Valley Rock festival in Septembermsn.com - February 23 at 7:09 PMEuro zone bond yields dip, data shows wage growth slowed in Q4msn.com - February 22 at 3:28 PMNektar Therapeutics Stock (NASDAQ:NKTR) Insider Tradesbenzinga.com - February 22 at 10:28 AMWill Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Knowfinance.yahoo.com - February 20 at 3:42 PMEquities Analysts Offer Predictions for Nektar Therapeutics' Q1 2024 Earnings (NASDAQ:NKTR)marketbeat.com - February 19 at 1:35 AMNektar Therapeutics (NASDAQ:NKTR) Receives Average Rating of "Reduce" from Analystsmarketbeat.com - February 9 at 1:33 AMDiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officerfinance.yahoo.com - January 22 at 8:54 AMDiaMedica Appoints Lorianne Masuoka As Chief Medical Officermarkets.businessinsider.com - January 22 at 8:54 AMNektar Therapeutics (NASDAQ:NKTR) Short Interest Updatemarketbeat.com - January 14 at 7:19 AMNektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CAfinance.yahoo.com - January 3 at 6:13 PMFollowing a 75% decline over last year, recent gains may please Nektar Therapeutics (NASDAQ:NKTR) institutional ownersfinance.yahoo.com - December 30 at 12:56 PMNektar Therapeutics (NKTR) Latest Stock News & Headlines - Yahoo Financeca.finance.yahoo.com - December 21 at 3:03 PMNektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meetingfinance.yahoo.com - December 11 at 6:08 PMNektar (NKTR) Up 4% Since Last Earnings Report: Can It Continue?finance.yahoo.com - December 7 at 1:43 PMNektar Therapeutics Stock (NASDAQ:NKTR) Earnings Dates and Earning Callsbenzinga.com - November 10 at 12:59 AMPositive Report for Nektar Therapeutics (NKTR) from TD Cowenmarkets.businessinsider.com - November 10 at 12:59 AMTD Cowen Upgrades Nektar Therapeutics (NKTR)msn.com - November 10 at 12:59 AMNektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 9 at 9:57 AMAnalysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS) and Nektar Therapeutics (NKTR)markets.businessinsider.com - November 8 at 7:06 PMNektar Therapeutics (NKTR) Incurs Wider-Than-Expected Q3 Lossfinance.yahoo.com - November 8 at 2:06 PMRecap: Nektar Therapeutics Q3 Earningsbenzinga.com - November 7 at 7:56 PMNektar Therapeutics Q3 Loss decreases, but misses estimatesmarkets.businessinsider.com - November 7 at 7:56 PMA Preview Of Nektar Therapeutics's Earningsbenzinga.com - November 6 at 6:43 PM Get Nektar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NKTR and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. NKTR Media Mentions By Week NKTR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NKTR News Sentiment▼-0.200.32▲Average Medical News Sentiment NKTR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NKTR Articles This Week▼41▲NKTR Articles Average Week Get Nektar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NKTR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AVIR News Today OMER News Today MCRB News Today ADCT News Today ASMB News Today PYXS News Today XERS News Today INZY News Today XBIT News Today NBTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NKTR) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
